Uncategorized

User-friendly and accessible DNA test reports

Well-designed reports showing DNA test results facilitate the work of genetic consultants and help customers understand the test result. How did we approach such a difficult topic? Download the case study and learn more about our cooperation with Edisonda UX studio (text in Polish).

Polygenic risk score application including severe COVID-19

The vast majority of differences between humans is caused by variations in their DNA, usually by alterations within a single nucleotide (SNP – single nucleotide polymorphism). Traits related to our health and well-being are influenced by a large number of such SNPs scattered throughout the genome and affecting many genes. Importantly, while each SNP impacts

System for pharmacological interpretation of the human genome

Pharmacogenomics, according to the National Library of Medicine, is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup.

Expanding our R&D potential

We have co-authored 4 new papers as a result of a cooperation with multiple research institutes: 1)  Opposite regulation of piRNAs, rRNAs, and miRNAs in the blood after subarachnoid hemorrhage – this report describes alterations in sRNAs abundance levels in response to IA rupture in humans. The obtained results indicate novel mechanisms that may constitute

Genomics at scale – building reproducible, scalable workflows for genome-based medicine

Contemporary computational genomics is inseparable from all the technical hurdles that arise when there is a need to handle the amounts of data counted in petabytes. Nevertheless, the sheer volume of data is just a tip of an iceberg. When considering the clinical applications, the true challenge stems from both the nature of the processed

We’re ISO 13485 certified!

We can proudly announce that our company has successfully passed the audit for the ISO 13485:2016 – Quality Management System for Medical Devices. The certificate was granted for the “design, manufacture, and sale of a medical device in the form of software supporting genetic diagnostics”. ISO 13485 specifies the way a company implements quality management

Intelliseq recognized by FDA

In October 2019, we participated in the BioCompute Object (BCO) App-a-thon organized by PrecisionFDA partnered with George Washington University and FDA/CBER HIVE (US Food and Drug Administration High Performance Virtual Environment group). The app-a-thon task was to create a BCO for at least two-step bioinformatics pipeline and/or create an application, which helps with the creation,

Partnership for Innovation

Attending the “Partnership for Innovation” conference. Our representatives, Klaudia and Michał, took part in the “Partnership for Innovation” conference organized at the Cracow University of Technology and co-hosted by the American Chamber of Commerce in Poland. The event was a great opportunity to present our services in front of the other innovative companies and potential